ipilimumab,nivolumab,cabozantinib
exelixis,bms
['cosmic313']
saving the best for last five phase 3 #kidneycancer trials culminating in the #cosmic313 presentation today! #esmo22 
I treat & research GU cancers @UTSW Dallas. Columbia/Harvard Med/Duke alum; Mom & wife Tweets=my opinions ASCO: https://t.co/Whk29PATXe